Plasma osteopontin levels are higher in patients with primary aldosteronism than in patients with essential hypertension

American Journal of Hypertension

Volumn 19, Issue 3, 2006, Pages 293-297

  Irita, Jun ^a   Okura, Takafumi ^a   Manabe, Seiko ^a   Kurata, Mie ^a   Miyoshi, Ken Ichi ^a   Watanabe, Sanae ^a   Fukuoka, Tomikazu ^a   Higaki, Jitsuo ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Inflammatory cytokine; Osteopontin; Primary aldosteronism

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; OSTEOPONTIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; MALE; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE;

ADULT; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; INTERLEUKIN-6; MALE; MIDDLE AGED; OSTEOPONTIN; SIALOGLYCOPROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 32944475760     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2005.08.019     Document Type: Article

References (35)

1. S.C. Young, H. Shionoiri, I. Takasaki, M. Kihara, E. Gotoh Hypertensive complications in patients with primary aldosteronism. A retrospective study Curr Ther Res 50 1991 317 325
2. R. Takeda, T. Matsubara, I. Miyamori, H. Hatakeyama, T. Morie The Research Committee of Disorders of Adrenal Hormones in Japan Vascular complications in patients with aldosterone-producing adenoma in Japan comparative study with essential hypertension J Endocrinol Invest 18 1995 370 373
3. P. Milliez, X. Girerd, P.F. Plouin, J. Blacher, M.E. Safar, J.J. Mourad Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism J Am Coll Cardiol 45 2005 1243 1248
4. E.R. Blasi, R. Rocha, A.E. Rudolph, E.A.G. Blomme, M.L. Polly, E.G. McMahon Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats Kidney Int 63 2003 1791 1800
5. R. Rocha, A.E. Rudolph, G.E. Frierdich, D.A. Nachowiak, B.K. Kekec, E.A.G. Blomme, E.G. McMahon, A.J.A. Delyani Aldosterone induced a vascular inflammatory phenotype in the rat heart Am J Physiol Heart Circ Physiol 283 2002 1802 1810
6. R. Rocha, P.N. Chander, K. Khanna, A. Zuckerman, C.T. Stier Jr Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats Hypertension 31 1998 451 458
7. B. Pitt, F. Zannad, W.J. Remme, R. Cody, A. Castaigne, A. Perez, J. Palensky, J. Wittes Randomized Aldactone Evaluation Study Investigator The effect of spironolactone on morbidity and mortality in patients with severe heart failure N Engl J Med 341 1999 709 717
8. L.E. Bautista, L.M. Vera, I.A. Arenas, G. Gamarra Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension J Hum Hypertens 19 2005 149 154
9. C.U. Chae, R.T. Lee, N. Rifai, P.M. Rider Blood pressure and inflammation in apparently healthy men Hypertension 38; 2001 399 403
10. L.E. Bautista, P. Lopez-Jaramillo, L.M. Vera, J.P. Casas, A.P. Otero, A.I. Guaracao Is C-reactive protein an independent risk factor for essential hypertension? J Hypertens 19 2001 857 861
11. M. Cesari, B.W.J.H. Pnninx, A.B. Newman, S.B. Kritchevsky, B.J. Nicklas, K. Sutton-Tyrrell, S.M. Rubin, J. Ding, E.M. Simonsick, T.B. Harris, M. Pahor Inflammatory markers and onset of cardiovascular events results from the Health ABC study Circulation 108 2003 2317 2322
12. T. Ikeda, T. Shirasawa, Y. Esaki, S. Yoshiki, K. Hirokawa Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta J Clin Invest 92 1993 2814 2820
13. C.M. Giachelli, N. Bae, M.M. Almeida, D.T. Denhardt, C.E. Alpers, S.M. Schwartz Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques J Clin Invest 92 1993 1686 1696
14. L. Liaw, D.M. Lombardi, M.M. Almeida, S.M. Schwartz, D. Deblois, C.M. Giachelli Neutralizing antibodies directed against osteopontin inhibit rat carotid neointimal thickening after endothelial denudation Arterioscler Thromb. Vasc Biol 17 1997 188 193
15. J.W. Conn, R.F. Knopf, R.M. Nesbit Clinical characteristics of primary aldosteronism from an analysis of 145 cases Am J Surg 107 1964 159 172
16. W.F. Young Primary aldosteronism - changing concepts in diagnosis and treatment Endocrinology 144 2003 2208 2213
17. D. Clarke, R. Wilkinson, I.D. Johnston, P.M. Hacking, J.W. Haggith Severe hypertension in primary aldosteronism and good response to surgery Lancet 313 1979 482 485
18. T. Suzuki, H. Abe, S. Nagata, F. Saitoh, S. Iwata, A. Ashizawa, M. Kuramochi, T. Omae Left ventricular structural characteristics in unilateral renovascular hypertension and primary aldosteronism Am J Cardiol 62 1988 1224 1227
19. G.A. Rossi, Z.L. Rossi, A. Calabro, G. Crepaldi, A.C. Pessina Prevalence of extracranial carotid artery lesions at duplex in primary aldosteronism Am J Hypertens 6 1993 8 14
20. Y. Shigematsu, M. Hamada, H. Okayama, Y. Hayashi, K. Kodama, K. Kohara, K. Hiwada Left ventricular hypertrophy precedes other target-organ damage in primary aldosteronism Hypertension 29 1997 723 727
21. G.P. Rossi, V.D. Bello, C. Ganzaroli, A. Sacchetto, M. Cesari, A. Bertini, D. Giorgi, R. Scognamiglio, M. Mariani, A.C. Pessina Excess aldosterone is associated with alterations of myocardial texture in primary aldosteronism Hypertension 40 2001 23 27
22. M. Lombes, M.-E. Oblin, J.-M. Gasc, E.E. Baulieu, N. Farman, J.-P. Bonvalet Immunohistochemical and biochemical evidence for a cardiovascular mineralcorticoid receptor Circ Res 71 1992 503 510
23. P.M. Ridker On evolutionary biology, inflammation, infection, and causes of atherosclerosis Circulation 105 2002 1758 1759
24. G.D. Smith, D.A. Lawlor, R. Harbord, N. Timpson, A. Rumley, G.D.O. Lowe, I.N.M. Day, S. Ebrahim Association of C-reactive protein with blood pressure and hypertension Arterioscler Thromb Vasc Biol 25 2005 1 6
25. K.C. Sung, J.Y. Sun, B.S. Kim, J.H. Kang, H. Kim, M.H. Lee, J.R. Park, S.W. Kim High sensitivity C-reactive protein as an independent risk factor for essential hypertension Am J Hypertens 16 2003 429 433
26. R. Ohmori, Y. Momiyama, H. Taniguchi, R. Takahashi, M. Kusuhara, H. Nakamura, F. Ohsuzu Plasma osteopontin levels are associated with the presence and extent of coronary artery disease Atherosclerosis 170 2003 333 337
27. K. Isoda, K. Nishikawa, Y. Kamezawa, M. Yoshida, M. Kusuhara, M. Moroi, N. Tada, F. Ohsuzu Osteopontin plays an important role in the development of medial thickening and neointimal formation Circ Res 91 2002 77 82
28. Y. Matsui, S.R. Rittling, H. Okamoto, M. Inobe, N. Jia, T. Shimizu, M. Akino, T. Sugawara, J. Morimoto, C. Kimura, S. Kon, D. Denhardt, A. Kitabatake, T. Uede Osteopontin deficiency attenuates atherosclerosis in female apolipoprotein E-deficient mice Arterioscler Thromb Vasc Biol 23 2003 1029 1034
29. N.A. Trueblood, Z. Xie, C. Communal, F. Sam, S. Ngoy, L. Liaw, A.W. Jenkins, J. Wang, D.B. Sawyer, O.H.L. Bing, C.S. Apstein, W.S. Colucci, K. Singh Exaggerated left ventricular dilation and reduced collagen deposition after myocardial infarction in mice lacking osteopontin Circ Res 88 2001 1080 1087
30. F. Sam, Z. Xie, H. Ooi, D.L. Kerstetter, W.S. Colucci, M. Singh, K. Singh Mice lacking osteopontin exhibit increased left ventricular dilation and reduced fibrosis after aldosterone infusion Am J Hypertens 17 2004 188 193
31. D. deBlois, D.M. Lombardi, E.J. Su, A.W. Clowes, S.M. Schwartz, C.M. Giachelli Angiotensin II induction of osteopontin expression and DNA replication in rat arteries Hypertension 28 1996 1055 1063
32. D. Bruemmer, A.R. Collins, G. Noh, W. Wang, M. Territo, S. Arias-Magallona, M.C. Fishbein, F. Blaschke, U. Kintscher, K. Graf, R.E. Law, W.A. Hsueh Anhiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice J Clin Invest 112 2003 1318 1331
33. Y. Matsui, N. Jia, H. Okamoto, S. Kon, H. Onozuka, M. Akino, L. Liu, J. Morimoto, S.R. Ritting, D. Denhardt, A. Kitabatake, T. Uede Role of osteopontin in cardiac fibrosis and remodeling in angiotensin II-induced cardiac hypertrophy Hypertension 43 2004 1195 1201
34. A.R. Collins, J. Schnee, W. Wang, S. Kim, M.C. Fishbein, D. Bruemmer, R.E. Law, S. Nicholas, R.S. Ross, W.A. Hsueh Osteopontin modulates angiotensin II-induced fibrosis in the intact murine heart J Am Coll Cardiol 43 2004 1698 1705
35. J.H. Kim, S.J. Skates, T. Uede, K.K. Wong, J.O. Schorge, C.M. Feltmate, R.S. Berkowitz, D.W. Cramer, S.C. Mok Osteopontin as a potential diagnostic biomarker for ovarian cancer JAMA 287 2002 1671 1679